These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37052231)

  • 1. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin.
    Rejdak K; Sienkiewicz-Jarosz H; Bienkowski P; Alvarez A
    Med Res Rev; 2023 Sep; 43(5):1668-1700. PubMed ID: 37052231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
    Masliah E; Díez-Tejedor E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():3-24. PubMed ID: 22514792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes.
    Fiani B; Covarrubias C; Wong A; Doan T; Reardon T; Nikolaidis D; Sarno E
    Neurol Sci; 2021 Apr; 42(4):1345-1353. PubMed ID: 33515100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries.
    Bornstein N; Poon WS
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():43-61. PubMed ID: 22514794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat.
    Sharma HS; Zimmermann-Meinzingen S; Johanson CE
    Ann N Y Acad Sci; 2010 Jun; 1199():125-37. PubMed ID: 20633118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on cerebrolysin in dementia.
    Plosker GL; Gauthier S
    CNS Drugs; 2010 Mar; 24(3):263-6. PubMed ID: 20155999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury.
    Zhang Y; Chopp M; Meng Y; Zhang ZG; Doppler E; Winter S; Schallert T; Mahmood A; Xiong Y
    J Neurosurg; 2015 Apr; 122(4):843-55. PubMed ID: 25614944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
    Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J
    Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.
    Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG
    J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study.
    Khalili H; Niakan A; Ghaffarpasand F
    Clin Neurol Neurosurg; 2017 Jan; 152():34-38. PubMed ID: 27871029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods.
    Poon W; Vos P; Muresanu D; Vester J; von Wild K; Hömberg V; Wang E; Lee TM; Matula C
    J Neurotrauma; 2015 Apr; 32(8):571-80. PubMed ID: 25222349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke.
    Zhang C; Chopp M; Cui Y; Wang L; Zhang R; Zhang L; Lu M; Szalad A; Doppler E; Hitzl M; Zhang ZG
    J Neurosci Res; 2010 Nov; 88(15):3275-81. PubMed ID: 20857512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials.
    Thome J; Doppler E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():63-9. PubMed ID: 22514795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain.
    Bondarenko O; Saarma M
    Front Cell Neurosci; 2021; 15():682597. PubMed ID: 34149364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
    Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC
    Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin: a multi-target drug for recovery after stroke.
    Brainin M
    Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neurogenesis via neurotrophic factors in acupuncture treatments for neurological diseases.
    Shin HK; Lee SW; Choi BT
    Biochem Pharmacol; 2017 Oct; 141():132-142. PubMed ID: 28461125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke.
    Poljakovic Z; Supe S; Ljevak J; Starcevic K; Peric I; Blazevic N; Krbot-Skoric M; Jovanovic I; Ozretic D
    Clin Neurol Neurosurg; 2021 Aug; 207():106767. PubMed ID: 34214867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.